Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Regeneron

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Regeneron's Japan sales performance.

regeneron

US court backs Sanofi/Regeneron in PCSK9 patent dispute with Amgen

US court backs Sanofi/Regeneron in PCSK9 patent dispute with Amgen Latest point in tit-for-tat battle between rivals. A US district court has handed a win to Sanofi and Regeneron in their five-year-old patent dispute with Amgen over ... Amgen filed a patent infringement complaint against Sanofi/Regeneron in 2014,

TMC rockets on data for twice-yearly cholesterol drug inclisiran

TMC rockets on data for twice-yearly cholesterol drug inclisiran That is a much less frequent dosing regimen than Amgen and Sanofi/Regeneron’s antibody-based PCSK9 inhibitors, inclisiran’s closest competitors, which are given every one to two months. ... Analysts suggest that dosing schedule could help inclisiran

Regeneron scores positive data in phase 3 cholesterol trial

Regeneron scores positive data in phase 3 cholesterol trial Targets severe inherited disorder. Regeneron’s pipeline candidate evinacumab reduced LDL cholesterol by 49% in patients with an inherited disorder which causes high cholesterol levels. . ... Regeneron and partner Sanofi have another approved

Dupixent drives Sanofi again, but other new drugs are lagging

Dupixent drives Sanofi again, but other new drugs are lagging A lot of the recovery is due to Regeneron-partnered Dupixent, which contributed 496m in the quarter – a rise of 181%. ... Regeneron books sales of the drug in the US. Shares in Sanofi rose just over 2% of the strength of the raised forecast and

Innovation and digital health comms recognised at Communiqué Awards

Innovation and digital health comms recognised at Communiqué Awards Innovation in Healthcare Communications. One high profile winning campaign was Havas Lynx Group’s ‘See Below’ on behalf of Sanofi Genzyme and Regeneron.

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia
...
Patients are ready for virtual clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...

Infographics